- Report
- May 2024
- 173 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- May 2024
- 177 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- May 2024
- 178 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- March 2024
- 155 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- February 2024
- 173 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- January 2024
- 168 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 163 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 165 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 158 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 166 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 163 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 173 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 151 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- November 2023
- 156 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- November 2023
- 163 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- October 2024
- 146 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- August 2024
- 163 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- June 2024
- 143 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- December 2023
- 160 Pages
Global
From €2401EUR$2,500USD£2,004GBP
- Report
- October 2024
- 200 Pages
Global
From €3601EUR$3,750USD£3,006GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more